Meeting
2021 ASCO Annual Meeting
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
Authors
Kumiko Umemoto
St. Marianna University School of Medicine, Kawasaki, Japan
Kumiko Umemoto , Hiroyuki Yamamoto , Ritsuko Oikawa , Hiroyuki Takeda , Ayako Doi , Yoshiki Horie , Takashi Ogura , Takuro Mizukami , Naoki Izawa , Jay A. Moore , Ethan Sokol , Yu Sunakawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4124)
DOI
10.1200/JCO.2021.39.15_suppl.4124
Abstract #
4124
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Genomics and translational precision oncology for 803 patients with biliary tract cancer.
First Author: Jianzhen Lin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox
Poster
2023 ASCO Annual Meeting
Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.
First Author: Subotheni Thavaneswaran
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA-based genomic landscape of early-onset pancreatic cancer.
First Author: Reagan Barnett